Effects of Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan) on intestinal function in streptozotocin-induced diabetic rats

Yakugaku Zasshi

Volumn 127, Issue 9, 2007, Pages 1509-1513

  Hirotani, Yoshihiko ^a,b   Ikeda, Takuya ^b   Ikeda, Kenji ^a,b   Yamamoto, Kaoru ^b   Onda, Mitsuko ^c   Arakawa, Yukio ^b,c   Li, Jun ^d   Kitamura, Kazuyuki ^d   Kurokawa, Nobuo ^b  

^a OSAKA OHTANI UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY HOSPITAL   (Japan)

^c OSAKA MEDICAL COLLEGE   (Japan)

^d Yanaihara Institute Inc   (Japan)

Author keywords

Disaccharidase activity; Glucagon like peptide 2 (GLP 2); Hachimi jio gan (Ba Wei Di Huang Wan); Rat; Small intestine; Streptozotocin

Indexed keywords

DISACCHARIDASE; GLUCAGON LIKE PEPTIDE 2; HACHIMIJIOGAN; MONOSACCHARIDE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DNA CONTENT; INTESTINE EPITHELIUM; INTESTINE FUNCTION; INTESTINE MUCOSA; MALE; NONHUMAN; RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; CELL PROLIFERATION; DIABETES MELLITUS, EXPERIMENTAL; DISACCHARIDASES; DISEASE MODELS, ANIMAL; DNA; DRUGS, CHINESE HERBAL; GLUCAGON-LIKE PEPTIDE 2; HYPERPLASIA; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; ORGAN SIZE; PHYTOTHERAPY; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 34548440717     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.127.1509     Document Type: Article

References (22)

1. Stratton I. M., Adler A. I., Neil H. A., Matthews D. R., Manley S. E., Cull C. A., Hadden D., Turner R. C., Holman R. R., BMJ, 321, 405-412 (2000).
2. The Diabetes Control and Complications Trial Research Group, N. Engl. J. Med., 329, 977-986 (1993).
3. Hosokawa H., Hirayama T., Yabana T., Nihon Rinsyo, 55, 896-905 (1997).
4. Feldman M., Schiller L. R., Ann. Intern. Med., 98, 378-384 (1983).
5. Goya R. K., Spiro H. M., Med. Clin. North Am., 55, 1031-1044 (1971).
6. Granneman J. G., Stricker E. M., Am. J. Physiol., 247, R1054-1061 (1984).
7. Fisher K. D., Dhanvantari S., Drucker D. J., Brubaker P. L., Am. J. Physiol., 273, E815-820 (1997).
8. Tandon R. K., Srivastava L. M., Pandey S. C., Am. J. Clin. Nutr., 28, 621-625 (1975).
9. Sharma S. D., Sivakami S., Biochem. Mol. Bio. Int., 44, 647-656 (1998).
10. Luo W. Q., Kanno T., Winarto A., Iwanaga T., Jun L., Futai Y., Yanaihara C., Yanaihara N., Biomed. Res., 190, 127-133 (1998).
11. Kim H. Y., Yokozawa T., Cho E. J., Yamabe N., J. Pharm. Pharmacol., 56, 1299-1305 (2004).
12. Brubaker P. L., Crivici A., Izzo A., Ehrlich P., Tsai C. H., Drucker D. J., Endocrinology, 138, 4837-4843 (1997).
13. Hirotani Y., Yamamoto K., Ikeda K., Arakawa Y., Li J., Kitamura K., Kurokawa N., Tanaka K., Biol. Pharm. Bull., 29, 2327-2330 (2006).
14. Jeppesen P. B., Hartmann B., Thulesen J., Graft J., Lohmann J., Hansen B. S., Tofteng F., Poulsen S. S., Madsen J. L., Mortensen P. B., Gastroenterology, 120, 806-815 (2001).
15. Dahlqvist A., Anal. Biochem., 22, 99-107 (1968).
16. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. T., J. Biol. Chem., 193, 265-275 (1951).
17. LePecq J. B., Paoletti C., Anal. Biochem., 17, 100-107 (1966).
18. Kato I., Jun L., Kitamura K., Tada H., Yanaihara N., Hirotani Y., Yamamoto K., Kurokawa N., Yanaihara C., "Peptide Science 1999," ed. by Fujii N., The Japanese Peptide Society, 2000, pp. 159-162.
19. Hirotani Y., Ikeda T., Yamamoto K., Kurokawa N., Biol. Pharm. Bull., 30, 1015-1020 (2007).
20. Xiao Q., Boushey R. P., Drucker D. J., Brubaker P. L., Gastroenterology, 117, 261-263 (1999).
21. Hirotani Y., Taki N., Kataoka K., Kurokawa N., Satoh T., Sasaki K., Yanaihara C., Luo W., Yanaihara N., Ann. N. Y. Acad. Sci., 865, 601-605 (1998).
22. Drucker D. J., Erlich P., Asa S. L., Brubaker P. L., Proc. Natl. Acad. Sci. U.S.A., 93, 7911-7916 (1996).